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RegulatoryT (Treg) cells constitute a distinctT cell subset, which plays a key role in immune
tolerance and homeostasis.The transcription factor Foxp3 controls a substantial part ofTreg
cell development and function. Yet its expression alone is insufficient for conferring devel-
opmental and functional characteristics of Treg cells. There is accumulating evidence that
concurrent induction of Treg-specific epigenetic changes and Foxp3 expression is crucial
for lineage specification and functional stability of Treg cells. This review discusses recent
progress in our understanding of molecular features of Treg cells, in particular, the mole-
cular basis of how a population of developing T cells is driven to the Treg cell lineage and
how its function is stably maintained.
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INTRODUCTION
Regulatory T (Treg) cells represent a subset of CD4+ T cells spe-
cialized for the maintenance of immune tolerance and homeostasis
by suppressing excessive and aberrant immune reactions harmful
to the host. While the majority of Treg cells develop in the thymus,
some are induced from naïve CD4+ T cells in the periphery. In
order for Treg cells to exert their regulatory functions, constitu-
tive expression of the transcription factor Foxp3 is essential (Hori
et al., 2003; Williams and Rudensky, 2007). The pivotal roles of
Foxp3 in Treg cell function and development are best illustrated
by the manifestation of multi-organ autoimmune inflammation
in FOXP3-deficient Immunodysregulation Polyendocrinopathy
Enteropathy X-linked syndrome (IPEX) patients and Scurfy mice
(Bennett et al., 2001; Brunkow et al., 2001; Fontenot et al., 2003).
Also as demonstrated by retroviral transduction of Foxp3 in con-
ventional CD4+ T (Tconv) cells, Foxp3 expression, combined with
T cell receptor (TCR) stimulation, enables the acquisition of Treg
properties including suppressive function, hyporesponsiveness to
TCR stimulation, and up-regulation of Treg-associated molecules
including CTLA-4, GITR, and CD25 (Hori et al., 2003; Yagi et al.,
2004). Foxp3 is therefore recognized as a master regulator of Treg
cell function and development.
In addition to the expression of Foxp3, several comprehensive
analyses have recently revealed possible involvement of other mol-
ecular mechanisms in the development of Treg cells. For example,
genome-wide comparison of DNA methylation status in Tconv
and Treg cells has demonstrated the presence of Treg-specific
DNA hypomethylation in the genes associated with Treg func-
tion (Schmidl et al., 2009; Ohkura et al., 2012). Proteomic analysis
in Treg cells indicates that Foxp3 forms complexes with a number
of co-factors to exert cooperative effects upon interaction (Rudra
et al., 2012). Furthermore, combinations of Foxp3 with several
other transcription factors are able to induce a common Treg-
type gene expression pattern, which cannot be achieved solely by
Foxp3 (Fu et al., 2012). These findings suggest that the generation
of functional Treg cells requires more than just the expression of
Foxp3.
With the indispensable roles of Foxp3 in exerting Treg cell func-
tion, stable expression of Foxp3 is a critical factor in Treg cell
development. However, from fate-mapping studies using Foxp3
reporter mice, it is becoming apparent that while the majority of
Treg cells are stable, a minor fraction of Foxp3+ T cells shows plas-
ticity and becomes non-Treg cells by losing Foxp3 (Komatsu et al.,
2009; Zhou et al., 2009). Furthermore, both human and murine
naïve CD4+ T cells transiently express Foxp3, without acquiring
suppressive function (Allan et al., 2007; Wang et al., 2007; Miyao
et al., 2012). These observations suggest the existence of two types
of Foxp3+ T cells, stable functional Treg cells and Foxp3+ naïve-
like non-Treg cells, and raise questions regarding the mode of
action of Foxp3 in these two populations. Although both pop-
ulations express Foxp3, Foxp3+ naïve-like non-Treg cells lack a
significant part of Treg-specific molecular features such as epige-
netic modifications. These findings prompt us to reconsider the
molecular mechanisms underlying Treg cell development. In this
review, we discuss key molecular features that make up functional
Treg cells.
CD4+Foxp3+ T CELLS ARE NOT ALWAYS Treg CELLS
In most physiological settings, CD4+Foxp3+ T cells stably main-
tain suppressive functions irrespective of environmental changes.
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However, recent studies suggest that the link between Foxp3
expression and suppressive activity is not so clear-cut, as there are
a number of anomalies for this molecular definition of Treg cells.
One example is a fraction of human Foxp3+ T cells. CD4+Foxp3+
T cells in humans can be divided into three subgroups; CD45RA+
Foxp3lo naïve Treg cells, CD45RA− Foxp3hi effector Treg cells, and
CD45RA− Foxp3lo T cells, and the last does not possess suppressive
function despite the expression of Foxp3 (Miyara et al., 2009). In
line with this, human naïve T cells express Foxp3 upon TCR stim-
ulation, yet this Foxp3 expression is transient and does not confer
suppressive property (Wang et al., 2007). Similarly, CD4+Foxp3lo
T cells are observed as a minor fraction of activated Tconv cells
in mice; these cells lack Treg-type gene expression and suppres-
sive activity and their unstable expression of Foxp3 results in the
generation of exFoxp3 T cells capable of producing inflammatory
cytokines (Miyao et al., 2012). These findings indicate that Foxp3
is not exclusively expressed in Treg cells.
Consistently, Foxp3 expression can be induced by some tran-
scription factors, irrespective of whether it accompanies Treg func-
tion or not. There are a number of molecules identified to initiate
and/or enhance the transcription of Foxp3, such as Smad3, NFAT,
Nr4a2, and AP-1 (Mantel et al., 2006; Tone et al., 2008; Sekiya et al.,
2011). This indicates that the combination of signals activating
these molecules is sufficient to induce Foxp3 expression. In fact,
in response to TCR stimulation and TGF-β signaling, a substantial
proportion of naïve CD4+Foxp3− T cells express Foxp3. How-
ever, murine in vitro-induced Treg (iTreg) cells have been revealed
to differ from thymus-derived Treg (tTreg) or periphery-derived
Treg (pTreg) cells in vivo. Firstly, they have only partial coverage of
Treg-type gene expression profile (Sugimoto et al., 2006; Hill et al.,
2007). Secondly, when antigen-specific iTreg cells are transferred
into normal mice and immunized with the specific antigen, Foxp3
expression is rapidly lost (Chen et al., 2011). Furthermore, while
in vivo-generated Treg cells are able to prevent colitis development
following transfer of CD4+CD45RBhigh T cells into lymphopenic
mice, the same number of iTreg cells can only moderately sup-
press the disease progress, partially due to the gradual loss of Treg
signature molecule expression (Ohkura et al., 2012). In addition,
human naïve T cells also express FOXP3 upon TCR and TGF-β
stimulation, yet these iTreg cells are reported to lack suppressive
function and produce pro-inflammatory cytokines (Tran et al.,
2007). Therefore, in vitro generated iTreg cells are another example
of Foxp3+ naïve-like non-Treg cells. As these findings demon-
strate, activating Foxp3 transcription does not necessarily indicate
the generation of Treg cells, suggesting the importance of widening
our focus onto other elements required for Treg cell development
and function.
THE MOLECULAR BASIS OF Foxp3-DEPENDENT Treg
CHARACTERISTICS
Foxp3 expression does not always correlate with Treg function.
In addition, at the molecular level, the contribution of Foxp3 to
the Treg-specific gene expression appears to be limited (46% of
upregulated genes and 28% of downregulated genes in natural
Treg cells were Foxp3-dependent) (Hill et al., 2007). This notion
is supported by the analysis of Foxp3-binding sites in Treg cells;
only a small proportion of the genes differentially expressed in
Treg cells are bound and directly regulated by Foxp3 (Zheng et al.,
2007). Collectively, these findings suggest that Foxp3 is an essential
factor for modulating a substantial part of Treg cell properties, yet
Foxp3 alone is insufficient to convert non-Treg cells into Treg cells
with full Treg-type gene expression and function. Given the major
loss of Treg cell function upon deletion of Foxp3, it is likely that
the mode of action of Foxp3 is different in functional Treg cells
and Foxp3+ naïve-like non-Treg cells.
There are several known mechanisms of Foxp3-mediated tran-
scriptional control (Figure 1). While some gene expression in Treg
cells is directly modulated by the binding of Foxp3 to their pro-
moters or enhancers, other gene expression requires interaction
of Foxp3 with other transcription factors. Recently, Rudra et al.
(2012) identified the comprehensive list of proteins forming com-
plexes with Foxp3 in Treg cells and revealed that a number of
these co-factors are transcription factors directly upregulated by
Foxp3, suggesting that direct up-regulation of co-factors by Foxp3
is followed by secondary regulation of gene expression by the com-
plexes of Foxp3 and its co-factors. In fact, it has been shown that
interactions of Foxp3 with Runx1/Cbfβ, NFAT, or Gata-3 are cru-
cial for the Foxp3-dependent gene expression and consequently
Treg cell function (Wu et al., 2006; Ono et al., 2007; Kitoh et al.,
2009; Rudra et al., 2012). Another recent study has shown that
co-expression of Foxp3 with at least one of the “quintet factors”
which include five transcription factors GATA-1, IRF4, Lef1, Ikzf4,
and Satb1 induces the same pattern of gene expression covering
a substantial part of Treg signatures, which is not achieved by the
expression of Foxp3 alone (Fu et al., 2012). Therefore, transcrip-
tional regulation by Foxp3 can be direct or indirect, and the latter
involves recruitment of co-factors to expand and specify Foxp3
targets. The composition of Foxp3-containig complexes is likely
to be variable at different genomic loci and may also be influenced
at the cellular level by immunological contexts, allowing dynamic
regulation of Foxp3-dependent transcription programs.
In this regard, Foxp3 exerts significant impact on the phe-
notypes and function of Treg cells by cooperating with other
transcriptional factors. Foxp3+ naïve -like non-Treg cells observed
in both humans and mice lack the expression of the majority
of Treg-associated molecules (Miyara et al., 2009; Miyao et al.,
2012), and this may be partially attributed to the lack of Foxp3
interaction with co-factors and consequently the lack of Treg phe-
notypes and function. As illustrated by iTreg cells induced in vitro,
Foxp3 expression can be induced by activating a set of transcrip-
tion factors and altering histone modifications at promoter and
enhancer regions. However, for the development of functionally
stable Treg cells, it is likely to require Foxp3 expression, together
with the expression of its partner molecules, and also other factors
regulating Foxp3-independent features of Treg cells.
EPIGENETIC FEATURES OF Treg CELLS
The heterogeneity of CD4+Foxp3+ T cells shows the need for
an additional marker in order to distinguish between functional
Treg cells and Foxp3+ naïve-like non-Treg cells. One of key dif-
ferences between these two populations is the stability of Treg
phenotypes. In search of the molecular determinant of this feature,
recent studies have focused on the epigenetics, a more stable level
of transcriptional regulation. Epigenetic changes include histone
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FIGURE 1 | Various mechanisms of Foxp3-dependent gene regulation in
Treg cells. Some genes are directly regulated by Foxp3 alone (A), while
others require the protein complexes containing Foxp3 and its co-factors for
transcriptional regulation. Foxp3 can interact with pre-existing transcription
factors such as Runx1 and Ets-1 (B) or with direct targets of Foxp3-mediated
gene regulation, such as GATA-3 (C) (Rudra et al., 2012). Furthermore, there
are also genes regulated by both Foxp3 and epigenetic changes. For example,
at Foxp3 locus, epigenetic modifications unveil normally hidden enhancer and
allow the transcriptional activation by Foxp3 and its co-factors (D) (Floess
et al., 2007; Schmidl et al., 2009; Zheng et al., 2010).
modification, DNA methylation of CpG residues, and nucleosome
repositioning. These events alter the accessibility of transcription
factors and RNA polymerase to regulatory regions of the genome,
thereby stably switching on and off the gene transcription. This
level of transcriptional regulation is particularly important in
cell differentiation in eukaryotes, allowing the stability of cell
type-specific gene expression.
Several groups have discovered that such epigenetic changes
take place in the course of Treg cell differentiation. Treg cells are
associated with DNA hypomethylation at Foxp3 conserved non-
coding sequence 2 (CNS2) and it was shown to be required for
stable expression of Foxp3 (Floess et al., 2007; Kim and Leonard,
2007). Furthermore, DNA demethylation also concurrently takes
place within the genes known as “Treg signatures,” namely Foxp3,
Ctal4, Ikzf2 (Helios), Ikzf4 (Eos), and Tnfrsf18 (GITR) (Ohkura
et al., 2012). These changes are specific to Treg cell develop-
ment and not induced in response to TCR or TGF-β stimula-
tion (Polansky et al., 2008; Ohkura et al., 2012). Accordingly,
in vitro generated iTreg cells and Foxp3+ naïve-like non-Treg cells
observed in humans and mice show the lack of Treg-specific DNA
hypomethylation, which correlates with the lack of a significant
part of Treg-type gene expression and stability of Treg signa-
ture molecule expression (Miyara et al., 2009; Miyao et al., 2012;
Ohkura et al., 2012). In addition to stabilizing Treg phenotypes,
epigenetic components of Treg cells also appear to regulate the
Treg-type gene expression pattern, either independently of Foxp3
or cooperatively with Foxp3. Gene expression analysis of Foxp3-
null Treg cells, which contain disrupted Foxp3 gene and fluorescent
marker controlled by the Foxp3 promoter, shows that a set of genes
including many of the Treg signatures are expressed even without
Foxp3 expression and that Foxp3 amplifies the pre-established
gene expression profile (Gavin et al., 2007). These Foxp3-null Treg
cells also possess Treg-specific DNA methylation pattern, which
correlates with the corresponding gene expression (Ohkura et al.,
2012).
One of the consequences of having Treg-specific DNA
demethylation is enhanced and ensured expression of Treg signa-
ture molecules by increasing accessibility of enhancers by constitu-
tively expressed transcription factors. In general,DNA methylation
interferes with binding of transcriptional factors by masking the
consensus sequence with methyl group or by preferentially attract-
ing methyl-CpG-binding proteins such as MBD family members,
MeCP2 and Kaiso (Tost, 2010). Thus, removal of methyl group
from DNA increases the accessibility for transcriptional factors
and allows their transcriptional regulation. In fact, insertion of
non-methylated Foxp3 CNS2 region, but not methylated one, into
a reporter construct significantly increased the luciferase reporter
activity (Schmidl et al., 2009; Polansky et al., 2010). This indicates
that Foxp3 CNS2 contains a transcriptional enhancer which is nor-
mally hidden by DNA methylation but becomes active along Treg
cell development. In line with this, CREB and Ets-1, transcription
factors essential for Treg function, bind to CNS2 of Foxp3 depend-
ing on its methylation status (Kim and Leonard, 2007; Mouly
et al., 2010; Polansky et al., 2010). Furthermore, the transcrip-
tional activation via this enhancer can be achieved by factors not
specifically expressed in Treg cells, as similar increase in transcrip-
tion activity occurred in both Tconv cells and Jurkat cells (Schmidl
et al., 2009; Polansky et al., 2010). This suggests that once Treg-
specific demethylation is complete, the target gene expression is
ensured by constitutively expressed regulatory proteins as long as
the methylation status is maintained. This role of DNA methyla-
tion status is further supported by the phenotypes of CNS2-null
www.frontiersin.org May 2013 | Volume 4 | Article 106 | 3
Kitagawa et al. Molecular aspects of Treg development
Treg cells, which lose Foxp3 expression gradually as they divide,
demonstrating the link between transcriptional control at CNS2
and Foxp3 expression stability (Zheng et al., 2010). Since Treg-
specific demethylated regions are present at the core set of Treg
signature genes, epigenetic changes during Treg cell development,
represented by DNA methylation status, may allow the phenotypes
to be inherited over numerous cell divisions, with stabilization of
the lineage commitment (Figure 2).
Collectively, these findings suggest that Treg-specific DNA
hypomethylation is induced simultaneously with Foxp3 induction
during natural Treg cell development and that these two molecular
events generate Treg-type gene expression synergistically in some
cases and independently in others. In addition, recent analysis of
DNase I hypersensitivity regions in Treg cells has demonstrated
differential DNase I sensitivity in a small fraction of genes in
Treg cells, when compared with naïve T cells; and these genes
mostly overlap with those that are specifically demethylated in Treg
cells (Ohkura et al., 2012; Samstein et al., 2012). Since both high
sensitivity to DNase I and DNA demethylation indicate an open
chromatin state and high accessibility of regulatory proteins, these
FIGURE 2 |The roles of epigenetic changes in stabilizing Foxp3
expression. Epigenetic changes during Treg cell development are important
for long-term stability of Treg phenotypes, particularly Foxp3 expression.
Foxp3 CNS2 in naïve CD4+ T cells shows repressive histone markers, low
accessibility for transcription factors, and methylated CpG residues, likely
attracting methyl-CpG-binding domains (MBDs). In the course of Treg cell
development, epigenetic changes take place and accessibility of CNS2
increases by DNA demethylation, histone modifications, and possibly
nucleosome repositioning (Ohkura et al., 2012; Samstein et al., 2012). The
CNS2 region serves as an enhancer for Foxp3 transcription and is bound by
transcription factors such as Foxp3, Ets-1, and CREB. These epigenetic
alterations are maintained irrespective of environmental changes and thus
allow stable Foxp3 transcription by constitutively expressed transcription
factors. In contrast, Foxp3 expression induced by TGF-β signaling and TCR
stimulation in vitro is unstable. These signals induce transcription factors,
such as NFAT, AP-1, and Smad3, which are capable of activating Foxp3
transcription, and TGF-β signaling can also alter histone modifications of the
Foxp3 locus (Tone et al., 2008). However, these features cannot be
maintained once TGF-β signaling and TCR stimulation are lost, resulting in loss
of Foxp3 transcription (Ohkura et al., 2012).
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two events may be linked, possibly as consequences of chromatin
remodeling. The mechanisms of epigenetic events which take place
during Treg cell development and the precise contribution of these
changes to the generation and maintenance of Treg cell characteris-
tics remain to be elucidated. Yet, a high correlation of Treg-specific
demethylation pattern with long-term stability and the function
of Treg cells suggests that the epigenetic pattern can be a reliable
marker to be used together with Foxp3 expression for identifying
those Treg cells which have completed their lineage commitment.
ESTABLISHMENT OF Treg CELL LINEAGE
As discussed in this review, recent comprehensive analyses of
Foxp3 protein complexes, genome-wide gene expression, and epi-
genetic modifications in Treg cells have revealed the complexity
of molecular mechanisms responsible for generating Treg phe-
notypes. Since most of these characteristics are not controlled
by Foxp3 alone, Treg cell development requires more than just
the induction of Foxp3. The existence of non-suppressive Foxp3+
naïve-like non-Treg cells also shows the difficulty of reliable Treg
delineation by Foxp3 expression alone. Treg cells which have
undergone specific epigenetic programs show Treg-specific DNA
demethylation as well as Foxp3 expression and exhibit full spec-
trum of Treg-type gene expression profile, indicating that epige-
netic conversion, induction of the core set of transcription factors,
formation of protein complexes are likely to occur simultane-
ously during the development of Treg cells. Notably, active DNA
demethylation at Foxp3 CNS2 region takes place during the thymic
Treg cell development, in parallel with the induction of Treg-type
gene expression and is completed as Treg cells migrate to the
periphery (Toker et al., 2013). Treg-specific DNA hypomethylation
is similarly observed in periphery-induced pTreg cells and there
is no significant difference in gene expression, with some excep-
tions, between tTreg cells and pTreg cells (Haribhai et al., 2011;
Ohkura et al., 2012). Recent studies have identified subpopulations
of Treg cells with distinct expression of additional transcription
factors such as T-bet, IRF4, Bcl6, and PPARγ (Koch et al., 2009;
Zheng et al., 2009; Linterman et al., 2011; Cipolletta et al., 2012).
Although the increase in phenotypic diversity within such Treg cell
populations apparently indicates the existence of heterogeneous
Treg subtypes, it may merely demonstrate the flexibility of natural
Treg cells, adapting to each immunological context for effective
immune suppression (Figure 3). As illustrated by the difference
between Treg cells and Foxp3+ naïve-like non-Treg cells, protein
expression can be transient and unstable, yet once the epigenetic
regulation is established to ensure the stability of key regulator
expression, the cells may achieve their lineage commitment and
maintain the phenotypes in various immunological contexts.
Recent genome-wide mapping of DNA methylation status in a
number of hematopoietic cells has revealed that as hematopoietic
stem cells undergo differentiation into different lineages such as T
cell and B cells, and CD4+ and CD8+ T cells, lineage-specific genes
are increasingly demethylated, whereas genes associated with other
lineages become methylated, in cells committed to a particular cell
lineage (Ji et al., 2010; Bock et al., 2012; Lee et al., 2012) (Figure 4).
Naïve T cells can also differentiate into helper T (Th) cells such
as Th1, Th2, Th17, Tfh, and presumably Th9, Th22 cells in the
periphery depending on environmental stimuli. Key transcription
factors such as T-bet, GATA-3, and RORγt, which modulates a
large set of gene expression to specify the phenotypes and func-
tions of Th1, Th2, and Th17 subset, respectively. Being similar to
the case with Foxp3 and Treg development, Th cell differentiation
is likely to involve epigenetic conversion in addition to the induc-
tion of transcription factors. Indeed, like Treg cells, which show
a specific DNA methylation pattern distinct from naïve T cells,
these Th cell subsets possess specific DNA methylation patterns
of the genes encoding cytokines and transcription factors associ-
ated with each subset (Lee et al., 2002; Ansel et al., 2003; Wilson
et al., 2009; Cohen et al., 2011; Ohkura et al., 2012; Thomas et al.,
2012). Furthermore, exposing Th1 cells to Th17-inducing stimuli
results in altered gene expression accompanying histone modifi-
cation, but not DNA demethylation of Th17-specific genes such as
the Il17a gene; similarly, Th17 cells in Th1-polarizing conditions
do not acquire DNA demethylation of Th1-specific genes such as
the Ifng gene (Cohen et al., 2011).
Taking these findings together, it is likely that changes in envi-
ronmental stimuli, for example, due to different types of inflam-
mation, may temporarily alter the gene expression and histone
modification, and render highly differentiated Treg or Th cells
adaptive to the environment with apparent plasticity, yet their
DNA methylation status may determine their basic cell lineage
commitment. However, assuming that even epigenetic changes
are theoretically reversible, plasticity of differentiated cells needs
further investigation to clarify whether any stimulation is able
to change DNA methylation status of terminally differentiated
cells, such as Treg cells, and drive them differentiate into other
lineages.
ARE Treg CELLS PLASTIC?
A number of recent reports have demonstrated possible plastic-
ity of Treg cells. Under a physiological condition, a fraction of
murine CD4+Foxp3+ T cells appear to lose Foxp3 expression
and become exFoxp3 T cells (Komatsu et al., 2009; Zhou et al.,
2009). Furthermore, the conversion of Foxp3+ T cells to exFoxp3
T cells is enhanced under lymphopenic conditions and Th1- and
Th17-polarizing conditions both in vivo and in vitro (Xu et al.,
2007; Yang et al., 2008; Oldenhove et al., 2009; Yurchenko et al.,
2012). Similarly, human Foxp3+ T cells also contain a fraction with
unstable Foxp3 expression (d’Hennezel et al., 2011). In contrast,
another study has demonstrated that Treg cells in peripheral lym-
phoid organs are capable of stably maintaining Foxp3 expression
in vivo even under inflammatory conditions (Rubtsov et al., 2010).
Analysis of DNA methylation status of the Foxp3 gene shows that
the Treg plasticity can simply be attributed to the presence of a
minor fraction of Foxp3+ T cells which lack Foxp3 hypomethyla-
tion (Miyao et al., 2012). Therefore, controversy regarding Treg
plasticity may be partly due to experimental variables; partic-
ularly in lymphopenic and IL-2 deficient conditions, expansion
of Foxp3+ naïve-like non-Treg cells and apoptosis of stable Treg
cells may appear as dramatic loss of Foxp3 expression in Treg
cells. As discussed in this review, Foxp3+ T cells include Treg cells
and non-Treg cells and it should be determined whether current
phenomena are due to the instability of the latter, or both. It is
important to resolve this matter of Treg plasticity, since some
of these exFoxp3 T cells possess auto-reactive TCRs, and thus
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FIGURE 3 | Adaptability ofTreg cells. Treg cells effectively regulate immune
responses in various contexts by flexibly adapting to the environments. While
most Treg cells are generated in the thymus, some are induced from Tconv
cells in the periphery, particularly in the intestine, where they play vital roles in
maintaining the immune homeostasis with commensal microbes. Recent
findings show that in local tissues such as adipose tissues, Treg cells, either
induced locally or migrating from the lymphoid organs, exhibit unique
characteristics, allowing specialized immune regulation (Cipolletta et al.,
2012). Furthermore, during inflammation, Treg cells respond to environmental
stimuli and adopt certain features of helper T cell characteristics to facilitate
the immune regulation (Koch et al., 2009; Zheng et al., 2009). However, there
are accumulating findings suggesting that strong stimulation by cytokines
such as IL-12 induces not only the additional transcription factors and
chemokine receptors but also pro-inflammatory cytokines in Treg cells
(Oldenhove et al., 2009; McClymont et al., 2011; Zhao et al., 2011; Koenecke
et al., 2012). Given the effects of pro-inflammatory cytokines in amplifying
inflammation, possible cytokine production by Treg cells present potential
hazard and might have relevance to chronic inflammation.
possibility of becoming harmful autoimmune effector T cells with
the capacity to secrete pro-inflammatory cytokines (Zhou et al.,
2009).
This plasticity issue also raises questions regarding the concept
of lineage commitment in T cell subsets. Is there a clear border-
line between each subset? If there are distinct signals to convert
naïve T cells into each T helper or Treg cell lineage, what happens
when Treg cells receive stimulation for T helper cell specification?
Is there a mechanism to prevent reprograming once the Treg lin-
eage is established? On this matter, the relationship between Treg
cells and Th1 cells are well demonstrated by Koch et al. Treg cells
express T-bet and CXCR3 upon exposure to IFN-γ; however, fur-
ther progression into Th1 differentiation is aborted since Treg
cells show delayed expression of IL-12 receptor, therefore being
less responsive to IL-12 signaling, which is required for IFN-γ
production (Koch et al., 2012). However, this scenario may only
apply to acute Th1-type infection where IL-12 production is tran-
sient enough to limit the IL-12 receptor expression on T-bet+ Treg
cells. Other reports have demonstrated the ability of Treg cells to
produce IFN-γ; for example, IFN-γ-producing Foxp3+ Treg cells
are observed in vivo during viral infections and acute graft-versus-
host disease in mice, and in patients with multiple sclerosis and
type I diabetes mellitus, and in several in vitro studies (Olden-
hove et al., 2009; Dominguez-Villar et al., 2011; McClymont et al.,
2011; Zhao et al., 2011; Koch et al., 2012; Koenecke et al., 2012).
If cytokines are capable of reprogramming Treg cells to produce
pro-inflammatory cytokines, it is potentially dangerous as it could
amplify the inflammatory responses by converting Treg cells to act
like effector T cells during chronic inflammation. It is noted, how-
ever, that the assessment of cytokine secretion often involves prior
stimulation with PMA/Ionomycin and whether Treg cells actually
produce significant amount of pro-inflammatory cytokines in vivo
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FIGURE 4 | DNA demethylation during hematopoietic cell
differentiation. Differentially methylated regions (DMRs) tends to be
detected within genes encoding molecules associated with lineage
specification, such as Cxcr2 and Gadd45α in granulocyte/macrophage
progenitors; Cd19, Irf8, and Cd79α in B cell lineage; and CD8a in CD8+ T
cells (Ji et al., 2010; Bock et al., 2012; Lee et al., 2012). Similarly, within
CD4+ T cell subsets, lineage-specific DNA demethylation occurs within
genes encoding molecules involved in cell subset-specific functions (Lee
et al., 2002; Ansel et al., 2003; Wilson et al., 2009; Cohen et al., 2011;
Ohkura et al., 2012; Thomas et al., 2012). These findings suggest the
involvement of epigenetic regulations during cell fate determination and
linage commitment.
is unclear. Future studies need to address whether these scenarios
are relevant during human diseases, whether there are alternative
failsafe mechanisms to prevent the reprograming of Treg cells or
whether this is the limit of Treg stability.
FUTURE PERSPECTIVES FOR CLINICAL APPLICATION OF Treg
CELLS
In this review, we have discussed how Treg cells can be molec-
ularly defined as a cellular entity. Differences among functional
definition (CD4+ T cells with suppressive function), molecular
definition (CD4+Foxp3+ T cells), and epigenetic definition (cells
with Treg-specific DNA methylation status) of Treg cells are neg-
ligible in most physiological settings. However, in the contexts of
various immunological diseases, the accuracy of Treg definition
matters. Some of the human naïve T cells and effector T cells are
capable of expressing Foxp3 in response to TCR activation (Allan
et al., 2007). In chronic autoimmune diseases, Foxp3 may be easily
expressed in activated Tconv cells by frequent TCR stimulation
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and this could potentially mask the underlying Treg deficiency
and/or dysfunction. Among currently identified autoimmune dis-
orders, only few of them are clearly linked to Treg abnormality
despite the well-studied roles of Treg cells in the maintenance of
self-tolerance (Gregersen and Behrens, 2006; Buckner, 2010). This
is partly due to technical difficulty to precisely assess Treg dys-
function, particularly if Foxp3+ T cells are present at a normal
or increased frequency. With the epigenetic features of Treg cells
revealed, it may be used as a new tool for assessing Treg function
and for better understanding of disease pathology.
Treg cells have crucial roles in maintaining immunological self-
tolerance and homeostasis and are suspected to be involved in a
variety of immunological disorders (Shevach, 2000; Maloy and
Powrie, 2001; Sakaguchi, 2004). Treg cells thus possess the poten-
tial to fix a wide range of immunological diseases from allergy to
cancer. For treatment of autoimmune disorders and allergy and for
efficient acceptance of grafts after transplantation, adoptive trans-
fer of Treg cells expanded ex vivo or induced in vitro is promising.
The ultimate goal of this approach is to control inflammation
with minimum adverse effects by using antigen-specific Treg cells.
However, little progress has been made toward practical applica-
tion of this idea due to the plasticity of some Foxp3+ T cells and
the lack of reliable cell surface markers for differentiating human
Treg cells from other activated T cells, which would increase the
chances of non-Treg cells or unstable Treg cells being contami-
nated and thus raise the concerns regarding safety and efficacy of
Treg cell therapy (Riley et al., 2009). Given low frequency of Treg
cells in human peripheral blood, an ideal approach is to generate
stable antigen-specific Treg cells in vitro from Tconv cells. Yet, cur-
rent method of iTreg generation using TGF-β and IL-2 can induce
Foxp3 protein expression, but these iTreg cells are significantly
different from in vivo Treg cells in terms of gene expression, epi-
genetics, stability, and function (Ohkura et al., 2012). As discussed
in this review, the epigenetic conversion and Foxp3 induction
are critical determinants of generating and maintaining stable
Treg cell lineage. The aims of future studies thus include better
understanding of signals and mechanisms required for these two
molecular events in the course of Treg cell development, which
may help us identify ways to generate and expand stable Treg cells
for therapeutic use.
CONCLUSION
Treg cell development involves concurrent induction of Foxp3
expression and epigenetic conversion, which cooperatively gener-
ate Treg-type gene expression. It is possible to induce the expres-
sion of Foxp3 in vitro; however, often it is not accompanied by
epigenetic changes or Treg-type gene expression. Foxp3 requires
its co-factors to potentiate its function in gene regulation and
confer suppressive activity on Treg cells. Furthermore, for long-
term lineage commitment of Treg cells, the stability of Foxp3 and
other Treg signature molecules need to be ensured by epigenetic
modification represented by DNA methylation status. Further
investigation will elucidate the mechanisms of epigenetic changes
as well as Foxp3 induction in the course of Treg cell development,
enabling us to devise new approaches for clinical application of
Treg cells.
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